CD8A and neoplasm: After treatment with anti-CD4 the number of IFNγ+CD8+ T cells in the DLN of mice with control EMT6 tumors was increased ~3-fold relative to PBS treated mice, in keeping with the decreased tumor growth (Fig 4B).